| NCT06821048 |
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors |
View |
| NCT02672917 |
Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies |
View |
| NCT02124317 |
Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer |
View |
| NCT05292859 |
Long-Term Follow-up Study of Subjects Treated With Autologous T Cells Using the Sleeping Beauty System to Express TCRs |
View |
| NCT01059097 |
Effect of Surgeon Volume on Outcome of Pancreaticoduodenectomy |
View |
| NCT05053555 |
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies |
View |
| NCT01050426 |
A Clinical Study of UFT/Leucovorin, Radiotherapy With or Without Cetuximab Following Induction Gemcitabine Plus Capecitabine in Patients With Locally Advanced Pancreatic Cancer (PERU) |
View |
| NCT02042378 |
A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation |
View |
| NCT06819215 |
Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors |
View |
| NCT00019435 |
LMB-9 Immunotoxin in Treating Patients With Advanced Solid Tumors |
View |
| NCT00454376 |
Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors |
View |
| NCT05681390 |
Tislelizumab With Anlotinib and Chemotherapy for Second-line Treatment of Pancreatic Cancer |
View |
| NCT05438797 |
The Safety and Efficacy of Specific TIL-TCM Cells for Advanced Relapse-refractory or Metastatic Pancreatic Cancer |
View |
| NCT04705818 |
Combining Epigenetic And Immune Therapy to Beat Cancer. |
View |
| NCT01969110 |
Additional Effects of Perioperative Immunonutrition in Patients Undergoing Pancreaticoduodenectomy |
View |
| NCT05485974 |
A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation |
View |
| NCT03375320 |
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors |
View |
| NCT05746182 |
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms |
View |
| NCT06705335 |
Convertases and Pancreatic Cancer: Cohort of Patients Treated for Pancreatic Adenocarcinoma |
View |
| NCT05252390 |
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors |
View |
| NCT02422147 |
EUS-guided Ablation of Pancreatic Cyst Neoplasms |
View |
| NCT02677038 |
Olaparib in Treating Patients With Stage IV Pancreatic Cancer |
View |
| NCT00274885 |
Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer |
View |
| NCT03816163 |
A Study of Zolbetuximab (IMAB362) in Adults With Pancreatic Cancer |
View |
| NCT04888312 |
Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients |
View |
